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17*β*E

:   17*β*‐estradiol

Ach

:   Acetylcholine

ASMCs

:   arterial smooth muscle cells

Ca~v~1.2

:   L‐type Ca^2+^ channels

Ca~v~

:   voltage‐gated

Endo

:   endothelium

ER

:   estrogen receptor

EtOH

:   ethanol

FPL64176

:   2,5‐Dimethyl‐4‐\[2‐(phenylmethyl)benzoyl\]‐1*H*‐pyrrole‐3‐carboxylic acid methyl ester

GPER

:   G‐protein‐coupled estrogen receptor

H~2~O~2~

:   hydrogen peroxide

HRP

:   horseradish peroxidase

ICI 182

:   780, 7*α*,17*β*‐\[9‐\[(4,4,5,5,5‐Pentafluoropentyl)sulfinyl\]nonyl\]estra‐1,3,5(10)‐triene‐3,17‐diol

RCA

:   right coronary artery

TBST

:   Tris‐buffered saline containing 0.1% Tween 20

TSG

:   thapsigargin

Introduction {#prp2358-sec-0001}
============

The in vivo administration of estrogen to postmenopausal women has a beneficial effect on coronary arterial function by improving blood flow (Gilligan et al. [1994](#prp2358-bib-0015){ref-type="ref"}; Puntawangkoon et al. [2010](#prp2358-bib-0040){ref-type="ref"}). The improvement in coronary blood flow during estrogen therapy is typically attributed to activation of Ca^2+^‐activated K^+^ channels and/or inhibition of voltage‐gated, L‐type Ca^2+^ (Ca~v~1.2) channels (Bowles et al. [1998a](#prp2358-bib-0004){ref-type="ref"},[b](#prp2358-bib-0005){ref-type="ref"}). The Ca~v~1.2 channels are the major pathway for voltage‐dependent Ca^2+^ influx in coronary arterial smooth muscle cells (ASMCs), and as primary mediators of arterial contraction, any imbalance in their activity or expression that favors Ca^2+^ influx may contribute to elevated vascular tone. For example, the expression of Ca~v~1.2 channels is increased in coronary arteries susceptible to vasospasm (Kuga et al. [2000](#prp2358-bib-0027){ref-type="ref"}), and Ca~v~1.2 channels are more abundant in small mesenteric and skeletal muscle arteries of genetically hypertensive rats (Pratt et al. [2002](#prp2358-bib-0039){ref-type="ref"}). Accordingly, the latter arteries exhibit accentuated Ca^2+^‐dependent vascular tone, which is normalized by pharmacological blockers of Ca~v~1.2 channels.

Using porcine coronary arteries, our laboratory (Tummala and Hill [2007](#prp2358-bib-0055){ref-type="ref"}; Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}) and others (Han et al. [1995](#prp2358-bib-0016){ref-type="ref"}; Teoh et al. [1999](#prp2358-bib-0048){ref-type="ref"}) demonstrated that the primary female estrogenic hormone, 17*β*‐estradiol (17*β*E), acutely inhibits contractions elicited by depolarizing KCl solutions, suggesting that 17*β*E reduces Ca^2+^ influx mediated by voltage‐sensitive Ca~v~1.2 channels. Similarly, Sudhir et al. ([1997](#prp2358-bib-0046){ref-type="ref"}) demonstrated that vasospasms of porcine coronary arteries are alleviated by the intracoronary infusion of 17*β*E, implying an inhibitory action of pharmacological concentrations of estrogen on coronary reactivity. Finally, Ullrich et al. ([2007](#prp2358-bib-0056){ref-type="ref"}) directly confirmed that 17*β*E (10 *μ*mol/L) inhibits whole‐cell Ca^2+^ current recorded from Ca~v~1.2 channel‐transfected HEK‐293 cells. In all of these studies, high concentrations (≥1 *μ*mol/L) of 17*β*E were required to reduce Ca^2+^ influx or mediate acute relaxation responses. In agreement with these studies (Han et al. [1995](#prp2358-bib-0016){ref-type="ref"}; Teoh et al. [1999](#prp2358-bib-0048){ref-type="ref"}; Tummala and Hill [2007](#prp2358-bib-0055){ref-type="ref"}; Ullrich et al. [2007](#prp2358-bib-0056){ref-type="ref"}; Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}), we confirmed that the acute relaxation responses to pharmacological concentrations of 17*β*E are nongenomic and relate to direct inhibition of Ca~v~1.2 channel function (Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}). However, a recurring concern of these in vitro studies is that the vasodilator effect of high pharmacological 17*β*E concentrations applied for short exposure times (≤60 min) cannot account for the in vivo effect of estrogen on vascular tone, which apparently results from chronic modulation of vascular contractile mechanisms by a much lower concentration of the circulating hormone. It is likely that 17*β*E\'s mechanism(s) of action on vascular tone is related to the duration of exposure (i.e., acute vs. chronic) and needs to be further investigated. For example, the estrogen receptor mediated intracellular signaling events (i.e., kinase phosphorylation) in vascular smooth muscle cells are enhanced with prolonged E2 exposure in culture (Ding et al. [2009](#prp2358-bib-0014){ref-type="ref"}).

Several studies have explored whether different in vivo estrogen levels modulate Ca~v~1.2 channel function in ASMCs. Using an ovariectomized rat model, Crews and Khalil (Crews and Khalil [1999](#prp2358-bib-0011){ref-type="ref"}) found less Ca^2+^ influx through Ca~v~1.2 channels in aortae isolated from ovary‐intact compared to ovariectomized females, implying that higher levels of circulating plasma estrogen may reduce the number of functional Ca~v~1.2 channels in ASMCs. Likewise, Bowles ([2001](#prp2358-bib-0003){ref-type="ref"}) found that coronary arteries of male pigs exhibit a higher expression level of the pore‐forming *α* ~1C~ subunit (Ca~v~ *α*) of the Ca~v~1.2 channel compared to female animals, and also show more voltage‐dependent Ca^2+^ current in patch‐clamped coronary ASMCs. Recently, Tharp et al. ([2014](#prp2358-bib-0051){ref-type="ref"}) elaborated on this study and demonstrated that coronary ASMCs from ovariectomized female pigs have increased Ca~v~1.2 channel current, but not enhanced Ca~v~ *α* protein expression, compared to ovary‐intact female pigs. The authors hypothesized that endogenous female hormones inhibit Ca~v~1.2 channel activity in coronary ASMCs by upregulating the Ca~v~ *β*1 subunit. In this regard, the Ca~v~ *α* pore proteins coassemble in 1:1 stoichiometry with smaller *β* and *α* ~2~ *δ* subunits to form functional Ca~v~1.2 channels in ASMCs; different *β* subunits modulate expression and properties of the multiprotein channel (Sonkusare et al. [2006](#prp2358-bib-0044){ref-type="ref"}; Kharade et al. [2013](#prp2358-bib-0026){ref-type="ref"}; Cox and Fromme [2015](#prp2358-bib-0010){ref-type="ref"}). Based on these in vivo studies, the objective of this study was to use an in vitro vessel culture approach to define the effect of 17*β*E on Ca~v~1.2 channel expression and function. 17*β*‐Estradiol is the main estrogenic hormone in premenopausal women, and is presumed to be one source of vascular protection (Khalil [2013](#prp2358-bib-0025){ref-type="ref"}). We used coronary arteries from sexually mature female pigs as a model because of their close similar to the human coronary vasculature, and similar development of coronary arterial dysfunctions and disease (Jokinen et al. [1985](#prp2358-bib-0021){ref-type="ref"}; Tummala and Hill [2007](#prp2358-bib-0055){ref-type="ref"}; Sturek [2011](#prp2358-bib-0045){ref-type="ref"}).

Materials and Methods {#prp2358-sec-0002}
=====================

Animals {#prp2358-sec-0003}
-------

As previously described (Tummala and Hill [2007](#prp2358-bib-0055){ref-type="ref"}), hearts from female Yorkshire pigs (3--4 years of age) were obtained from a local packing plant staffed with a United States Department of Agriculture veterinarian. The distal end of the right coronary artery (RCA) was immediately dissected from the heart in a low Ca^2+^ Krebs solution (in mmol/L: 138 NaCl, 5 KCl, 0.2 CaCl~2~, 1 MgCl~2~, 10 HEPES, 10 glucose, pH 7.4).

Vessel culture {#prp2358-sec-0004}
--------------

For tension‐recording studies, distal ends of the RCA were carefully sectioned into ring segments (4 mm in length) before placing each ring in the appropriate culture conditions. The RCA designated for real‐time PCR and Western blot analysis were sectioned into longitudinal strips (3 cm in length) prior to vessel culture. To determine the nonacute effect of 17*β*‐estradiol (17*β*E; Sigma Chemical Co., St. Louis, MO) on Ca~v~1.2 channel‐mediated coronary reactivity and Ca~v~ *α* expression, arterial segments were incubated at 37°C in a 5% CO~2~ incubator for 24 h in RPMI 1640 phenol‐free culture media (Sigma). Arteries either were incubated in: (1) control media, (2) media supplemented with 17*β*E (1 pmol/L to 10 *μ*mol/L), or (3) media supplemented with an equal volume of ethanol solvent (EtOH; 0.1%). In order to implicate specific estrogen receptors (ER), the media in some studies was supplemented either with the ER*α*/ER*β* antagonist, ICI 182,780 (Tocris Bioscience; Ellisville, MO) or the G‐protein‐coupled estrogen receptor (GPER) antagonist, G15 (Tocris Bioscience, Bristol, UK). The latter antagonist reportedly lacks affinity for ER*α* and ER*β* at concentrations up to 10 *μ*mol/L (Dennis et al. [2009](#prp2358-bib-0013){ref-type="ref"}; Yu et al. [2011](#prp2358-bib-0062){ref-type="ref"}). To evaluate the role of endothelium on the 17*β*E effects, the endothelium was removed in a subset of studies by rubbing the luminal vessel surface with a wooden toothpick before vessel culture; its removal was later verified using scanning electron microscopy.

Vascular reactivity {#prp2358-sec-0005}
-------------------

Isometric tension recording was performed using freshly isolated arterial rings or rings cultured for 24 h under one of the three conditions described above. Rings were suspended in organ baths (World Precision Instruments, Sarasota, FL) containing an oxygenated (95% O~2~: 5% CO~2~) modified Krebs solution (in mmol/L: 138 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 10 HEPES, 10 glucose, pH 7.4). All rings were initially stretched to their optimal length (Tummala and Hill [2007](#prp2358-bib-0055){ref-type="ref"}). To evaluate 17*β*E‐induced relaxation, the freshly isolated rings were preconstricted with a depolarizing solution containing high (60 mmol/L) KCl (in mmol/L: 83 NaCl, 60 KCl, 2 CaCl~2~, 1 MgCl~2~, 10 HEPES, 10 glucose, pH 7.4) followed by generation of a concentration--response relationship with 17*β*E (0.1*--*100 *μ*mol/L) or its EtOH solvent. As reported and discussed earlier (Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}), each 17*β*E concentration was equilibrated with the ring for 60 min (to achieve a steady‐state relaxation response) before the next sequential concentration was added.

The acute effect of 17*β*E on depolarization‐induced contractions also was evaluated using freshly isolated rings of RCA. An initial 80 mmol/L KCl‐mediated contraction was induced before incubating each ring in a different 17*β*E concentration (1 pmol/L to 100 *μ*mol/L) or its ethanol solvent (0.1%) for 60 min. This was followed by the generation of a KCl concentration--response relationship (15--80 mmol/L) in all rings. The composition of the KCl solution was a similar to the 60 mmol/L KCl solution described above except for the equimolar substitution of NaCl for KCl.

The concentration--response relationship with KCl was evaluated in rings cultured for 24 h in EtOH, or in 1 pmol/L, 1 nmol/L, and 10 *μ*mol/L 17*β*E. In contrast to the freshly used rings above, cultured rings were not exposed to 80 mmol/L KCl before generating the KCl concentration--response relationship; instead an "untreated group" was cultured without 17*β*E or EtOH. During the generation of the KCl concentration--response relationship, rings were allowed to incubate with each KCl solution for only 10 min before exchanging it for the sequential KCl concentration to minimize depolarization‐induced Ca~v~1.2 channel upregulation (Pesic et al. [2004](#prp2358-bib-0038){ref-type="ref"}).

In a subset of studies, the endothelium was denuded from arterial rings using a wooden toothpick prior to vessel culture. After a 24 h culture, the rings were suspended in organ baths and endothelial function was verified by the ability of bradykinin (0.1 *μ*mol/L; Sigma) to relax a 35 mmol/L KCl depolarizing contraction. In studies using the Ca~v~1.2 channel agonist, FPL64176, rings were exposed to acetylcholine (10 *μ*mol/L; Sigma) and thapsigargin (10 *μ*mol/L; Sigma) to release and eliminate the reuptake of Ca^2+^ back into the sarcoplasmic reticulum (SR), and thereby eliminate a potential effect of FPL64176 on SR Ca^2+^ release (Wasserstrom et al. [2002](#prp2358-bib-0060){ref-type="ref"}). A steady‐state contraction was generated to FPL64176 (3 *μ*mol/L; Tocris Bioscience) followed by application of the Ca~v~1.2 channel antagonist, nifedipine (10 *μ*mol/L; Sigma). Only arterial rings that contracted in response to FPL64176 and relaxed back to baseline in response to nifedipine were used for analysis.

Immunoblots {#prp2358-sec-0006}
-----------

Cultured strips of RCA were homogenized and membrane lysate prepared (Liu et al. [2001](#prp2358-bib-0030){ref-type="ref"}). Equivalent amounts of membrane proteins were run on a 4--15% polyacrylamide gradient gel. After electrophoresis, the proteins were electroblotted to a PVDF membrane. The membrane was subsequently blocked overnight (at 4°C) with 5% non‐fat dry milk dissolved in a Tris‐buffered saline containing 0.1% Tween 20 (TBST). After decanting off the blocking solution, the membrane was incubated in a 1:100 dilution of rabbit polyclonal anti‐*α* ~1C~ (Alomone Labs, Jerusalem, Israel) for 60 min followed by three washes (10 min each) using TBST. The membrane was then incubated with horseradish peroxidase (HRP) conjugated goat anti‐rabbit IgG (1:1000; Santa Cruz Biotech, Santa Cruz, CA) for 60 min and subsequently washed (3x) with TBST. Chemiluminescence permitted detection of the HRP‐labeled antibody using an AlphaImager Documentation and Analysis System (Alpha Innotech Corp., San Leandro, CA). Likewise, band densitometry was analyzed using AlphaImager software. Smooth muscle *β*‐actin (1:1000; Abcam, Cambridge, MA) was used as a loading control in Western blots.

Real‐time PCR {#prp2358-sec-0007}
-------------

The relative abundance of Ca~v~ *α* transcript in arterial strips cultured for 24 h in EtOH or 17*β*E (1 nmol/L) was determined by real‐time PCR (Tobin et al. [2009](#prp2358-bib-0053){ref-type="ref"}). Total RNA was isolated using the RNeasy^®^ protect mini‐kit (Qiagen, Germantown, MD). The resulting RNA was subjected to DNase treatment using DNA‐free^TM^ kit (Ambion, Austin, TX) to remove any contaminating DNA. Five hundred ng of the RNA isolate was reverse transcribed (iScript cDNA synthesis kit; Biorad, Hercules, CA) to generate cDNA. The cDNA was generated at 25°C for 5 min, followed by 42°C for 30 min and 85°C for 5 min. The cDNA sequences were then amplified by RT‐PCR (iQ^TM^ SYBR^®^ Green Supermix Kit; Biorad, Hercules, CA) using Ca~v~ *α* and *β*‐actin specific primers, and an iCycler iQ^®^ Multicolor Real Time PCR Detection System (Biorad, Hercules, CA). The forward and reverse primers used to amplify cDNA were reported earlier (Hirenallur et al. [2008](#prp2358-bib-0020){ref-type="ref"}): Ca~v~ *α* ‐ 5′‐ccgcccactaccaagatcaac‐3′ (forward) and 5′‐gcatctcgggctcctcctc‐3′ (reverse); *β*‐actin ‐ 5′‐accactggcattgtcatggactct‐3′ (forward) and 5′‐tcttcatgaggtagtcggtcaggt‐3′ (reverse). After initial denaturation at 95°C for 3 min, the following temperature‐cycling profile was used for amplification (40 cycles): 95°C for 10 sec denaturing and 62°C for 1 min for annealing and extension. *β*‐actin was used as an internal standard. Each amplification reaction contained 5 ng of the cDNA product. Control reactions contained all components except the cDNA template. The relative abundance of Ca~v~ *α* transcript in EtOH and 17*β*E‐treated arteries was quantified by the ΔΔCt method, and reported as percent of EtOH expression (Livak and Schmittgen [2001](#prp2358-bib-0031){ref-type="ref"}).

Scanning electron microscopy {#prp2358-sec-0008}
----------------------------

As reported by us earlier (Hill and Muldrew [2014](#prp2358-bib-0018){ref-type="ref"}), scanning electron microscopy was used to verify the integrity of the endothelium. Arterial strips were pinned lumen side up on a wax surface in individual glass jars, then fixed with 2% glutaraldehyde (Ted Pella, Inc., Redding, CA) for 60 min, and then postfixed with 4% osmium tetroxide (Ted Pella, Inc.) for an additional 60 min. The specimens were dehydrated using ascending ratios of acetone/ethanol (1:1, 2:1, 4:1) followed by descending ratios of acetone/hexamethyldisilazane (4:1, 2:1, 1:1). Next, the samples were sputter‐coated with gold particles and the luminal surface observed using a PSEM II 2000 scanning electron microscope (FEI, Hillsboro, OR).

Statistics {#prp2358-sec-0009}
----------

All data are expressed as the mean ± SE for the number (*n*) of animals within each group. When comparing two groups, significance was determined using an unpaired t‐test. The KCl concentration--response curves were analyzed using two‐way repeated measures ANOVA with a Holm--Sidak post hoc analysis. Significant effect of multiple 17*β*E concentrations was evaluated using one‐way ANOVA followed by Bonferroni\'s post hoc analysis. Potential endothelial effects were analyzed using a two‐way ANOVA (without replication) followed by Tukey HSD post hoc analysis. The EC~50~ values (‐log of the effective concentration required to generate a 50% maximal response) were calculated and analyzed using GraphPad Prism 4.0 (GraphPad Software Inc., San Diego, CA). Statistical analysis was conducted using JMP 8 Statistical Discovery (SAS Institute Inc., USA) using a level of critical significance of *α *= 0.05; therefore, significance was defined as *P* \< 0.05.

Results {#prp2358-sec-0010}
=======

Vascular reactivity responses {#prp2358-sec-0011}
-----------------------------

High concentrations of 17*β*Ε were necessary to relax depolarizing KCl‐induced contractions (Fig. [1](#prp2358-fig-0001){ref-type="fig"}), which fully rely on voltage‐dependent Ca^2+^ influx through Ca~v~1.2 channels. The progressive relaxation mediated by 17*β*E (0.1*--*100 *μ*mol/L) significantly attenuated contraction by 17.7 ± 2.4% and 61.3 ± 5.4% at concentrations of 10 *μ*mol/L and 100 *μ*mol/L 17*β*E, respectively (*n* = 7). EtOH served as a solvent and time control for the relaxation experiment. Likewise, when arterial rings were incubated with 17*β*E (1 pM to 100 *μ*mol/L) for 60 min prior to generation of KCl concentration--response curves, only 17*β*E concentrations of 10 *μ*mol/L and 100 *μ*mol/L significantly attenuated KCl contractions (Fig. [2](#prp2358-fig-0002){ref-type="fig"}; *n* = 5). A 17*β*E concentration of 1 nmol/L did not acutely relax arteries precontracted by KCl (data not shown) and preincubation for 60 min in 1 nmol/L 17*β*E did not suppress KCl concentration--response curves as shown in Figure [2](#prp2358-fig-0002){ref-type="fig"}.

![Pharmacological concentrations of 17*β*‐estradiol (17*β*E) are required to relax coronary arterial rings precontracted by 60 mmol/L KCl. (A) Typical recording shows concentration‐dependent relaxation by 17*β*E of a KCl‐contracted arterial ring. Exposure to KCl is indicated by the horizontal line. (B) Average values (mean ± SE) for 17*β*E‐induced relaxation of KCl precontracted rings. Equal volumes of EtOH served as solvent control. \**P* \< 0.05 using an unpaired *t*‐test, EtOH versus 17*β*E groups (*n* = 7 pigs).](PRP2-5-e00358-g001){#prp2358-fig-0001}

![A short‐term (60 min) preexposure to 17*β*E necessitates the use of high, pharmacological 17*β*E concentrations to inhibit depolarization‐induced contractions to KCl. Rings were incubated for 60 min in 1 pmol/L, 1 nmol/L, 1 *μ*mol/L, 10 *μ*mol/L, or 100 *μ*mol/L 17*β*E, or its EtOH solvent, before generating cumulative concentration--response relationships to KCl. The KCl‐induced tension development is expressed as percent (%) of the maximal contractile response to 80 mmol/L KCl before incubating rings in 17*β*E or EtOH. The data are shown as the mean ± SE and analysis was conducted using two‐way repeated measures ANOVA (Holm--Sidak post hoc). \**P* \< 0.05, 10 *μ*mol/L or 100 *μ*mol/L 17*β*E versus EtOH at the same KCl concentration (*n* = 5 pigs).](PRP2-5-e00358-g002){#prp2358-fig-0002}

In contrast, prolonged preexposure of similar arteries to 1 nmol/L 17*β*E attenuated depolarization‐induced contractions (Fig. [3](#prp2358-fig-0003){ref-type="fig"}). Coronary arterial rings cultured for 24 h prior to tension recording in RPMI media containing 1 nmol/L 17*β*E exhibited an \~25% attenuation of the concentration--response curves to KCl (Fig. [3](#prp2358-fig-0003){ref-type="fig"}). This inhibitory effect was accentuated in arterial rings preincubated in 10 *μ*mol/L 17*β*E for 24 h, whereas 1 pM 17*β*E had no significant effect on the KCl contraction. The acute (1 h) versus longer term (24 h) effects of 1 nmol/L 17*β*E on KCl contraction are compared in Table [1](#prp2358-tbl-0001){ref-type="table-wrap"}.

![Incubation of coronary arterial rings in a low concentration (1 nmol/L) of 17*β*Ε for 24 h attenuates the concentration--response curve to KCl. Cumulative concentration--response relationships to KCl were generated after rings were cultured for 24 h in 1pM, 1 nmol/L, or 10 *μ*mol/L 17*β*Ε or ethanol solvent (EtOH), or left untreated (no addition of 17*β*Ε or EtOH). The KCl contractions are expressed as percent (%) of the maximal contractile response to 80 mmol/L KCl of the untreated group (*n* = 5 pigs). The data are shown as the mean ± SE and analysis was conducted using two‐way repeated measures ANOVA (Holm--Sidak post hoc). \**P* \< 0.05, EtOH versus 1 nmol/L 17*β*Ε at the same KCl concentration. Likewise, **\^**denotes *P* \< 0.05, EtOH versus 10 *μ*mol/L 17*β*Ε at the same KCl concentration.](PRP2-5-e00358-g003){#prp2358-fig-0003}

###### 

Comparison between effects of acute (1 h) and prolonged (24 h) exposure to 17*β*‐estradiol (17*β*E) on EC~50~ values and maximal tension (T~max~) of KCl concentration--response relationships

  Exposure time     \[17*β*E\] or EtOH Solvent   *n*            EC~50~ (mmol/L)[a](#prp2358-note-0002){ref-type="fn"}   T~max~ [b](#prp2358-note-0003){ref-type="fn"}
  ----------------- ---------------------------- -------------- ------------------------------------------------------- -----------------------------------------------
  1 h               EtOH (0.1%)                  5              39.89 ± 1.01                                            102.81 ± 1.86
  1 pmol/L 17*β*E   5                            41.41 ± 1.01   96.96 ± 1.18                                            
  1 nmol/L 17*β*E   5                            40.87 ± 1.02   103.33 ± 7.01                                           
  24 h              EtOH (0.1%)                  5              41.01 ± 1.07                                            110.87 ± 3.83
  1 pM 17*β*E       5                            39.67 ± 1.07   96.17 ± 7.15                                            
  1 nmol/L 17*β*E   5                            44.06 ± 1.08   85.59 ± 5.50[c](#prp2358-note-0004){ref-type="fn"}      

KCl concentration required to reach one‐half maximal response to 80 mmol/L KCl.

Maximal contraction to 80 mmol/L KCl. Data are expressed as percent of maximal contractile response to the initial addition of 80 mmol/L KCl.

*P* \< 0.05, EtOH versus 1 nmol/L 17*β*E.

John Wiley & Sons, Ltd

17*β*E for 24 h results in loss of Ca~v~ *α* protein {#prp2358-sec-0012}
----------------------------------------------------

Corroborating our isometric tension‐recording findings of reduced Ca^2+^‐dependent contractions after prolonged exposure to 1 nmol/L 17*β*E, we also found that a 24 h exposure to 1 nmol/L 17*β*E decreased the expression of the pore‐forming *α* ~1C~ subunit of the Ca~v~1.2 channel, Ca~v~ *α*, by 35 ± 0.9% (Fig. [4](#prp2358-fig-0004){ref-type="fig"}A and B). The Western blots shown in Figure [4](#prp2358-fig-0004){ref-type="fig"} depict immunoreactive doublet bands corresponding to the short (\~200 kD) and long (\~240 kD) forms of the Ca~v~ *α* subunit. The EtOH solvent (0.1%) and 1 pmol/L 17*β*E did not significantly affect Ca~v~ *α* protein expression. Immunodensity of the internal standard, *β*‐actin, was similar between treatment groups.

![Exposure to 17*β*Ε for 24 h decreases the expression of the *α* ~1C~ pore‐forming subunit (Ca~v~ *α*) of the Ca~v~1.2 channel in coronary arterial strips. (A) Diffuse immunoreactive band corresponding to the Ca~v~ *α* protein; the short (\~200 kD) and long (\~240 kD) forms of Ca~v~ *α* are revealed as a doublet in some blots. *β*‐Actin (42 kDa) was used as an internal standard. Protein lysates were obtained from cultured arteries exposed for 24 h to the following conditions: lane 1 = untreated; lane 2 = EtOH (0.1%); lane 3 = 1 pmol/L 17*β*Ε; lane 4 = 1 nmol/L 17*β*Ε. B, The densitometric ratio corresponding to Ca~v~ *α* in arterial lysates exposed for 24 h to EtOH or 1 nmol/L 17*β*Ε compared to untreated arteries. Results indicate that 1 nmol/L 17*β*Ε for 24 h decreases Ca~v~ *α* protein abundance. Data represent mean ± S.E. (*n* = 5 pigs) and analyzed using one‐way ANOVA followed by Bonferroni\'s post hoc analysis. There was no difference in *β*‐actin expression between groups.](PRP2-5-e00358-g004){#prp2358-fig-0004}

Real‐time PCR was used to determine if 1 nmol/L 17*β*E reduced Ca~v~ *α* subunit abundance by transcriptional regulation. Initially, we standardized the real‐time PCR assay before comparing Ca~v~ *α* subunit mRNA levels. First, the presence of a single peak in the melt curve analysis inferred a single amplification product corresponding to Ca~v~ *α* amplified product. Second, we verified that the real‐time PCR assay was adequately sensitive to detect 50% change in the expression of amplification products corresponding to Ca~v~ *α* mRNA. Standard amplification curves generated for Ca~v~ *α* using twofold serial dilutions of cDNA from 12.5 ng to 1.56 ng per amplification reaction resulted in a one‐cycle (1.0 ± 0.1) increase in threshold cycle as predicted, thereby demonstrating sensitive detection of changes in transcript level in this range. After assay verification, the expression of Ca~v~ *α* transcript was compared between arteries cultured in EtOH solvent or 1 nmol/L 17*β*E for 24 h (Fig. [5](#prp2358-fig-0005){ref-type="fig"}A and B). Representative real‐time PCR curves indicated an average cycle threshold of 26.33 ± 0.52 for the detection of Ca~v~ *α* in EtOH‐treated arteries (*n* = 6) compared to 26.36 ± 0.59 in 17*β*E‐treated arteries (*n* = 6), implying similar abundance of the Ca~v~ *α* subunit transcript as estimated by the ΔΔCt method (Fig. [5](#prp2358-fig-0005){ref-type="fig"}C). In the same arterial preparations, as expected, similar cycle thresholds of 16.26 ± 0.35 (EtOH, *n* = 6) and 16.52 ± 0.39 (17*β*E, *n* = 6) also were calculated for the internal standard *β*‐actin.

![Exposure of arterial segments to 1 nmol/L 17*β*E for 24 h failed to alter expression of Ca~v~ *α* transcript. (A and B) Real‐time PCR amplifications of Ca~v~ *α* (A) and internal standard *β*‐actin (B) are similar between arteries cultured for 24 h in RPMI media containing 1 nmol/L 17*β*Ε or its solvent (EtOH). Relative fluorescence units. (B) Abundance of Ca~v~ *α* transcript is not significantly different between 17*β*Ε and EtOH‐treated arteries as analyzed by the ΔΔCt method. Data are expressed as percent (%) transcript expression in EtOH (*n* = 6 pigs).](PRP2-5-e00358-g005){#prp2358-fig-0005}

17*β*E‐induced inhibition of KCl contractions and Ca~v~ *α* expression is not endothelium dependent {#prp2358-sec-0013}
---------------------------------------------------------------------------------------------------

The effect of 24 h exposure to 1 nmol/L 17*β*E on Ca~v~1.2 channel function also was evaluated by comparing the contractile response to the Ca~v~1.2 channel agonist, FPL64176 (3 *μ*mol/L), between coronary rings exposed to the EtOH solvent or 17*β*E. Studies were performed in endothelium intact (+Endo) and denuded (‐Endo) arterial rings to evaluate if the inhibitory effect of 1 nmol/L 17*β*E on Ca~v~1.2 channel‐dependent contraction was mediated by endothelium‐derived factors. In addition to its intended role as a Ca~v~1.2 channel agonist, FPL64176 reportedly can induce Ca^2+^ release from the sarcoplasmic reticulum (SR) by opening ryanodine receptors (Wasserstrom et al. [2002](#prp2358-bib-0060){ref-type="ref"}; Vaithianathan et al. [2010](#prp2358-bib-0057){ref-type="ref"}). Therefore, as shown in Figure [6](#prp2358-fig-0006){ref-type="fig"}A, arteries were simultaneously exposed to 10 *μ*mol/L acetylcholine (Ach) and 10 *μ*mol/L thapsigargin (TSG) to induce SR Ca^2+^ release and prevent its reuptake by inhibiting Ca^2+^‐ATPase, respectively. Arteries incubated in 1 nmol/L 17*β*E elicited a contractile response to FPL64176 that was 47 ± 0.56% and 60 ± 0.33% less (*n* = 6) compared to control arteries (EtOH) in +Endo and ‐Endo rings, respectively (Fig. [6](#prp2358-fig-0006){ref-type="fig"}B). Overall, the presence or absence of the endothelium had no effect on FPL64176‐induced tension development (*P* = 0.26).

![Coronary arterial segments cultured for 24 h in 1 nmol/L 17*β*Ε show attenuated contractions to Ca~v~1.2 channel activation by 3 *μ*mol/L FPL64176. Endothelium intact (+Endo) and denuded (‐Endo) arteries were cultured in 1 nmol/L 17*β*Ε or its solvent (EtOH). A, Experimental protocol used to evaluate the contractile response to the Ca~v~1.2 channel agonist, FPL64176 (3 *μ*mol/L). To prevent a potentially confounding influence of FPL‐induced Ca^2+^ release from sarcoplasmic reticulum (SR), rings initially were exposed to acetylcholine (Ach, 10 *μ*mol/L) and thapsigargin (TSG, 10 *μ*mol/L) before evaluating the contractile response to FPL64176. Complete relaxation of FPL64176‐induced contractions by 10 *μ*mol/L nifedipine confirmed dependence on Ca~v~1.2 channels. (B) Composite data from studies depicted in panel A. Data are expressed as mean ± S.E. and analyzed using a two‐way ANOVA (without replication) followed by Tukey HSD post hoc analysis. \* *P* \< 0.05, EtOH ± Endo versus 17*β*Ε ± Endo; (*n* = 7 pigs).](PRP2-5-e00358-g006){#prp2358-fig-0006}

As shown by anti‐Ca~v~ *α* Western blots (Fig. [7](#prp2358-fig-0007){ref-type="fig"}), coronary arterial strips cultured in 1 nmol/L 17*β*E for 24 h exhibited a significant decrease in expression of the pore‐forming Ca~v~ *α* subunit of the Ca~v~1.2 channel in +Endo and ‐Endo arterial strips. The +Endo and --Endo arteries exposed to 17*β*E exhibited a densitometric ratio that was 62 ± 9% and 74 ± 14% of the control +Endo arteries treated with EtOH solvent, respectively. Western blot data are expressed as a ratio of Ca~v~ *α* expression in +Endo arteries exposed to EtOH. In a control set of experiments, the EtOH solvent had no effect on Ca~v~ *α* subunit expression between +Endo and ‐Endo arteries (*n* = 6, data not shown); the densitometric ratio (Ca~v~ *α*/*β*‐actin) was 1.01 ± 0.09 and 0.93 ± 0.17 for +Endo and --Endo arteries, respectively.

![17*β*Ε decreases expression of the Ca~v~ *α* pore‐forming subunit independently of endothelium. Upper panel shows a representative anti‐Ca~v~ *α* immunoblot from arteries with intact (+Endo) or denuded (‐Endo) endothelium, which were cultured for 24 h in RPMI media containing 1 nmol/L 17*β*Ε or ethanol (EtOH). 17*β*Ε decreased the densitometric ratio in intact and denuded arteries. *β*‐actin served as an internal standard. The images are from different parts of the same gel. The Ca~v~ *α* and *β*‐actin groupings were imaged separately. Band intensity between groups was normalized to *β*‐actin and expressed as a densitometric ratio of the EtOH+Endo group. Data represent mean ± SE (*n* = 7 pigs). \**P* \< 0.05, EtOH ± Endo versus 17*β*Ε ± Endo using a two‐way ANOVA (without replication) followed by Tukey HSD post hoc analysis.](PRP2-5-e00358-g007){#prp2358-fig-0007}

17*β*E‐induced loss of Ca~v~ *α* protein requires ER*α*/ER*β* {#prp2358-sec-0014}
-------------------------------------------------------------

Previously in Figs. [4](#prp2358-fig-0004){ref-type="fig"} and [7](#prp2358-fig-0007){ref-type="fig"}, we demonstrated a significant reduction in the Ca~v~ *α* subunit protein by 1 nmol/L 17*β*E. Figure [8](#prp2358-fig-0008){ref-type="fig"}A shows that the addition of the estrogen receptor (ER*α*/ER*β*) antagonist, ICI 182,780 (10 *μ*mol/L), to the RPMI media significantly prevented the decrease in Ca~v~ *α* protein expression induced by 24 h exposure to 1 nmol/L 17*β*E (*n* = 7). To investigate whether the G‐protein‐coupled estrogen receptor (GPER) also may mediate the 17*β*E‐induced reduction in Ca~v~1.2 channel expression, arterial strips were incubated for 24 h in 1 nmol/L 17*β*E in the presence of 10 *μ*mol/L G15, a selective GPER antagonist. This intervention failed to prevent the 17*β*E‐induced decrease in Ca~v~ *α* protein expression (Fig. [8](#prp2358-fig-0008){ref-type="fig"}B, *n* = 4).

![Loss of Ca~v~ *α* in cultured arteries exposed to 1 nmol/L 17*β*Ε for 24 h is prevented by pharmacological block of ER *α*/ER *β*. (A) The ER *α*/ER *β* antagonist ICI 182,780 (ICI, 10 *μ*mol/L) prevents 17*β*Ε‐induced downregulation of the Ca~v~ *α* subunit. Data represent mean ± SE (*n* = 7 pigs). (B) The G‐protein‐coupled estrogen receptor (GPER) antagonist, G15 (10 *μ*mol/L) failed to prevent a 17*β*Ε‐induced loss of Ca~v~ *α*. Data represent mean ± SEM. (*n* = 4 pigs) and are expressed as a densitometric ratio. \**P* \< 0.05 from EtOH using one‐way ANOVA followed by Bonferroni\'s post hoc analysis.](PRP2-5-e00358-g008){#prp2358-fig-0008}

Discussion {#prp2358-sec-0015}
==========

Evidence suggests that circulating estrogen contributes to protection of the female sex against elevated coronary vascular tone by reducing Ca^2+^ entry into ASMCs (Crews et al. [1999](#prp2358-bib-0012){ref-type="ref"}; Orshal and Khalil [2004](#prp2358-bib-0036){ref-type="ref"}; Tharp et al. [2014](#prp2358-bib-0051){ref-type="ref"}). Indeed, high concentrations of estrogen inhibit Ca^2+^ influx and attenuate Ca^2+^‐dependent contractions in isolated coronary arteries (Han et al. [1995](#prp2358-bib-0016){ref-type="ref"}; Teoh et al. [1999](#prp2358-bib-0048){ref-type="ref"}; Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}). However, a confounding finding is that in vitro inhibition of vascular reactivity is only observed at high concentrations of estrogen, which may exceed physiological concentrations by at least 1000‐fold (Han et al. [1995](#prp2358-bib-0016){ref-type="ref"}; Teoh et al. [1999](#prp2358-bib-0048){ref-type="ref"}; Salom et al. [2002](#prp2358-bib-0043){ref-type="ref"}; Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}; Reslan et al. [2013](#prp2358-bib-0041){ref-type="ref"}). This study addresses this concern with two major findings. First, we observed that a prolonged (24 h) rather than acute exposure to 17*β*E increases its potency as an inhibitor of Ca^2+^‐dependent contractions, such that 1 nmol/L 17*β*E significantly depresses contractions induced by depolarizing KCl and the Ca~v~1.2 channel agonist, FPL64176. Second, to our knowledge, we provide the first in vitro findings to directly demonstrate that 17*β*E results in a posttranscriptional decrease in Ca~v~1.2 channel expression. Our results corroborate in vivo sex studies, which have indirectly suggested that the presence of circulating estrogens in female subjects is associated with lower Ca^2+^ channel expression in coronary ASMCs, and thus, less Ca^2+^‐dependent tone developed by the coronary arteries (Bowles [2001](#prp2358-bib-0003){ref-type="ref"}; Bowles et al. [2004](#prp2358-bib-0006){ref-type="ref"}; Tharp et al. [2014](#prp2358-bib-0051){ref-type="ref"}). Because Ca~v~1.2 channels are the predominant pathway for voltage‐dependent Ca^2+^ influx in ASMCs of the coronary circulation (Bowles et al. [1998a](#prp2358-bib-0004){ref-type="ref"}), decreasing their expression in the plasma membrane of ASMCs will increase arterial diameter and promote coronary blood flow.

We used 1 nmol/L 17*β*E to correlate with previous in vitro studies that used 1 nmol/L 17*β*E as a near "physiological" E2 concentration to evaluate its effect on the vascular mechanics of arteries (Keung et al. [2005](#prp2358-bib-0023){ref-type="ref"}, [2011](#prp2358-bib-0024){ref-type="ref"}; Cignarella et al. [2009](#prp2358-bib-0008){ref-type="ref"}; Lekontseva et al. [2011](#prp2358-bib-0028){ref-type="ref"}). Therefore, we did not attempt to use a definite plasma 17*β*E concentration from cycling sows or premenopausal women because it is difficult to extrapolate in vitro results (which can differ based upon the experimental model) to the in vivo condition. In premenopausal women, circulating estrogen is primarily composed of 17*β*E, and its concentration approximates 0.2 nmol/L before ovulation; this value rises to 1 nmol/L at ovulation (Marsh et al. [2011](#prp2358-bib-0032){ref-type="ref"}), which is comparable to the 1 nmol/L 17*β*E concentration used in this study. In mature sows, the plasma estrogen concentration varies from 20 to 840 pmol/L depending on the estrous cycle (Cook et al. [1977](#prp2358-bib-0009){ref-type="ref"}; Chatrath et al. [2003](#prp2358-bib-0007){ref-type="ref"}). Despite differences in circulating estrogen levels between premenopausal women and our female pig model, there are many advantages to using porcine coronary arteries as a model in this study. The structural similarities of the cardiovascular system between pigs and humans have been well documented (Swindle et al. [2012](#prp2358-bib-0047){ref-type="ref"}). In addition, pig coronary arteries similarly express estrogen receptors (ER), ER*α* and ER*β*, as well as the G‐protein‐coupled estrogen receptor, GPER (Traupe et al. [2007](#prp2358-bib-0054){ref-type="ref"}; Yu et al. [2011](#prp2358-bib-0062){ref-type="ref"}). Overall, circulating plasma estrogens have been well documented to be responsible for differences in coronary vascular reactivity between sexes in swine (Barber and Miller [1997](#prp2358-bib-0002){ref-type="ref"}; Jones et al. [1999](#prp2358-bib-0022){ref-type="ref"}; Bowles [2001](#prp2358-bib-0003){ref-type="ref"}; Heaps and Bowles [2002](#prp2358-bib-0017){ref-type="ref"}).

The acute and nongenomic inhibition of Ca~v~1.2 channels in porcine coronary arteries by high concentrations of 17*β*E has been demonstrated by us and others (Han et al. [1995](#prp2358-bib-0016){ref-type="ref"}; Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}). As shown in this study, when coronary arteries are acutely (≤60 min) exposed to 17*β*E, a 17*β*E concentration of ≥1 *μ*mol/L is necessary to inhibit contractile responses to depolarizing KCl solutions. Similarly, our study confirms findings by Teoh et al. ([2000](#prp2358-bib-0049){ref-type="ref"}) that acutely exposing porcine coronary arteries to a lower 17*β*E concentration of 1 nmol/L fails to inhibit Ca^2+^‐dependent contractions. It is likely that the apparent lack of in vitro sensitivity to 17*β*E is partly due to the larger amount of connective tissue and increased diffusion distance of coronary arteries compared to small, resistance arteries. Only after a 24 h exposure to 17*β*E, were we able to demonstrate that 1 nmol/L 17*β*E attenuates the depolarization‐induced contractile response to KCl and inhibits contractions elicited by the Ca~v~1.2 channel agonist, FPL64176. Both of these contractile responses are mediated by voltage‐dependent Ca^2+^ influx through Ca~v~1.2 channels, as verified by their reversal by nifedipine, a selective Ca~v~1.2 channel antagonist (Wang et al. [2011](#prp2358-bib-0059){ref-type="ref"}; Owen et al. [2013](#prp2358-bib-0037){ref-type="ref"}).

Our findings further suggest that the attenuation of Ca^2+^‐dependent contractions observed after a 24 h exposure to 1 nmol/L 17*β*E is mediated by a posttranscriptional downregulation of the pore‐forming Ca~v~ *α* subunit of the Ca~v~1.2 channel. To our knowledge, no studies have reported an effect of near physiological estrogen levels on Ca~v~ *α* expression in ASMCs, although it is well recognized that Ca~v~1.2 channels are dynamically regulated in vivo by circulating factors and disease states. For example, an overabundance of arterial Ca~v~1.2 channels is a shared feature of pig, rat, and mouse models of hypertension, which also exhibit elevated myogenic tone and arterial reactivity (Molero et al. [2002](#prp2358-bib-0034){ref-type="ref"}; Pratt et al. [2002](#prp2358-bib-0039){ref-type="ref"}; Pesic et al. [2004](#prp2358-bib-0038){ref-type="ref"}; Hirenallur et al. [2008](#prp2358-bib-0020){ref-type="ref"}; Kharade et al. [2013](#prp2358-bib-0026){ref-type="ref"}). Likewise, Wang et al. ([2008](#prp2358-bib-0058){ref-type="ref"}) reported that angiotensin II increases Ca~v~ *α* subunit expression without changes in Ca~v~ *α* mRNA levels in cultured rat mesenteric arteries, implying involvement of posttranscriptional regulation of Ca~v~1.2. However, Tharp et al. ([2014](#prp2358-bib-0051){ref-type="ref"}) reported that ASMCs of female pigs subjected to ovariectomy exhibited a twofold increase in Ca^2+^ current in the absence of altered Ca~v~ *α* transcript or protein expression. Overall, these findings infer that the particular experimental model may determine the mechanism by which the abundance of Ca~v~1.2 channels is regulated in the plasma membrane (Mazzuca et al. [2015](#prp2358-bib-0033){ref-type="ref"}).

Importantly, our results suggest that the loss of Ca~v~1.2 channels in coronary arteries in response to 24 h exposure to 1 nmol/L 17*β*E is prevented by the estrogen receptor (ER*α*/ER*β*) antagonist ICI 182,780, whereas the GPER antagonist G15 has no effect. It remains unlikely that G15 was ineffective as a GPER inhibitor in our studies, because Yu et al. ([2011](#prp2358-bib-0062){ref-type="ref"}) previously used a similar concentration of G15 (3 *μ*mol/L) to inhibit the GPER‐mediated vasorelaxation induced by its selective agonist, G‐1, in porcine coronary arteries. Instead, our findings imply that 17*β*E may bind to ER*α*/ER*β* to alter posttranscriptional regulation of Ca~v~1.2 channels, a process that has not been defined in ASMCs. However, in nonvascular cell types and heterologous expression systems, the posttranscriptional mechanisms that regulate Ca~v~1.2 channel expression include ubiquitination and proteosomal degradation of the Ca~v~ *α* subunit (Altier et al. [2011](#prp2358-bib-0001){ref-type="ref"}; Rougier et al. [2011](#prp2358-bib-0042){ref-type="ref"}). Thus, it is possible that ER*α*/ER*β* signaling disrupts the fine balance between Ca~v~1.2 channel biogenesis and degradation, potentially resulting in a loss of Ca~v~1.2 channels at the plasma membrane.

The relaxation response to high, pharmacological concentrations of estrogen relies on direct inhibition of Ca^2+^ influx into coronary ASMCs, and does not require the vascular endothelium (Gilligan et al. [1994](#prp2358-bib-0015){ref-type="ref"}; Han et al. [1995](#prp2358-bib-0016){ref-type="ref"}; Nakajima et al. [1995](#prp2358-bib-0035){ref-type="ref"}; Hill et al. [2010](#prp2358-bib-0019){ref-type="ref"}; Yang and Reckelhoff [2011](#prp2358-bib-0061){ref-type="ref"}). However, the endothelium has been implicated in the regulation of Ca~v~1.2 channel expression in ASMCs (Wang et al. [2008](#prp2358-bib-0058){ref-type="ref"}, [2011](#prp2358-bib-0059){ref-type="ref"}). Therefore, this study also sought to define the contribution of endothelium to the 17*β*E‐induced loss of Ca~v~1.2 channels and Ca^2+^‐dependent contractions. However, we failed to find a role for the endothelium in 17*β*E actions. Instead, the 17*β*E‐mediated decrease in Ca~v~1.2 channel numbers appears to be mediated by ER*α*/ER*β* expressed by ASMCs, and we suggest the downregulation of Ca~v~1.2 channels by ER*α*/ER*β* may attenuate the development of abnormal coronary arterial tone. The ER*α*/ER*β*‐mediated, endothelium‐independent dilation and decrease in voltage‐gated Ca2 +  influx has been similarly shown using rat mesenteric microvessels (Mazzuca et al. [2015](#prp2358-bib-0033){ref-type="ref"}).

Although our porcine coronary artery model offers many experimental advantages, several limitations of this study should be acknowledged. First, as discussed earlier, we did not use a defined "physiological" plasma 17*β*E concentration. Although our porcine coronary artery model offers many experimental advantages, we cannot ensure our results directly translate to the human condition. Second, the limitations of in vitro vascular studies that remove ASMCs from modulating endogenous influences and place them in artificial vessel culture conditions are appreciated. In earlier studies (Lindqvist et al. [1999](#prp2358-bib-0029){ref-type="ref"}; Thorne and Paul [2003](#prp2358-bib-0052){ref-type="ref"}), and also here, we used serum‐free RPMI media to maintain arterial contractility and avoid cell proliferation. Third, we attempted to perform whole‐cell patch clamp on ASMCs freshly isolated from our cultured coronary arteries to directly confirm a loss of functional Ca~v~1.2 channels in response to 17*β*E. However, we were unable to maintain the high resistance (≥10 GΩ) seals required for high‐quality recordings of Ca^2+^ currents, although we routinely record ion currents from ASMCs freshly isolated from many other arterial preparations (Pesic et al. [2004](#prp2358-bib-0038){ref-type="ref"}; Hirenallur et al. [2008](#prp2358-bib-0020){ref-type="ref"}; Thakali et al. [2010](#prp2358-bib-0050){ref-type="ref"}; Kharade et al. [2013](#prp2358-bib-0026){ref-type="ref"}). For this reason, our study relied on two different vascular reactivity assays using depolarizing KCl solution and FPL64176, which directly activate Ca~v~1.2 channels in ASMCs in situ to allow for detection of changes in Ca~v~1.2 channel function.

In conclusion, this study provides initial evidence that a nonacute, low concentration of 17*β*E for 24 h results in loss of functional Ca~v~1.2 channels in porcine coronary arteries, and this event appears to rely on posttranscriptional modifications enacted by 17*β*E through ER*α*/ER*β* signaling. This finding is significant because most in vitro studies have used high pharmacological estrogen concentrations to emphasize the antagonistic effects of estrogen on Ca^2+^ signaling in ASMCs and on arterial contraction. It is possible that this previously unrecognized effect of estrogen contributes to the attenuation of coronary vascular contractions reported by sex studies in females compared to males (Jones et al. [1999](#prp2358-bib-0022){ref-type="ref"}; Bowles [2001](#prp2358-bib-0003){ref-type="ref"}; Tharp et al. [2014](#prp2358-bib-0051){ref-type="ref"}).
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